| 标题 |
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Barbara Burtness; Kevin J. Harrington; Richard Greil; Denis Soulières; Makoto Tahara; et al 出版日期:2019-11-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)